BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Incline Therapeutics 



Menlo Park  California  94025  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
The Medicines Company (MDCO) Completes Acquisition of Incline Therapeutics 1/7/2013 9:42:10 AM
Cadence Pharmaceuticals, Inc. Announces Termination of Option Agreement to Acquire Incline Therapeutics 12/12/2012 9:26:37 AM
The Medicines Company (MDCO) to Acquire Incline Therapeutics for About $185 Million 12/12/2012 7:04:50 AM
Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer 5/10/2012 12:07:56 PM
Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference 3/1/2012 10:46:14 AM
Incline Therapeutics to Present at the Leerink Swann and Company 2012 Global Healthcare Conference 2/13/2012 10:15:32 AM
Incline Therapeutics Announces Acquisition of IONSYS(TM) from ALZA Corporation (JNJ) and $43 Million Series A Financing 6/22/2010 9:02:44 AM
Cadence Pharmaceuticals, Inc. May Buy Incline Therapeutics for up to $285 Million 6/22/2010 6:55:01 AM